Microarray and immunohistochemical surveys reveal Trop2 overexpression in approximately 83% of BC specimens relative to normal breast tissue, and functional studies across multiple laboratories have demonstrated that Trop2 drives cancer-cell proliferation in vitro and tumor expansion in vivo [5,13,44]. Here, TACSTD2 is linked to neoplasm.